Revance · 2 months ago
3rd Shift Machine Operator 11:00 P.M. -07:15 A.M.
Revance is a fast-growing global aesthetics and skincare company focused on providing innovative products. They are seeking a 3rd Shift Machine Operator responsible for maintaining filling machines, ensuring quality production, and performing preventative maintenance.
BiotechnologyHealth CarePharmaceuticalTherapeutics
Responsibilities
Set-up, clean, repair and maintain equipment to meet our production schedules
Monitor machines during every procedure to ensure optimum running
Troubleshoot problems during machine operation
Ensure that regular and preventative maintenance procedures are carried out
Perform random tests to ensure accuracy
Ensure that machines are producing quality products by monitoring periodic checks on output
Maintain activity logs
Assist in other areas as needed
Qualification
Required
High school diploma
Preferred
Vocational training as a machine operator, with 2-3 years of experience
Must be mechanically inclined with good troubleshooting skills
Attention to detail a must
Benefits
Competitive Compensation including base salary and annual performance bonus
Paid time off, holidays, and floating holidays that can be used for whatever you choose
Generous healthcare benefits, Employer HSA match, 401k match, wellness discounts and much more
Company
Revance
We believe that science-powered innovation creates possibilities.
H1B Sponsorship
Revance has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (12)
2024 (16)
2023 (8)
2022 (10)
2021 (16)
2020 (3)
Funding
Current Stage
Public CompanyTotal Funding
$1.68BKey Investors
Athyrium Capital Management LPEssex Woodlands Healthcare PartnersMedicis Pharmaceutical
2024-08-12Acquired
2024-03-04Post Ipo Equity· $100M
2022-09-12Post Ipo Equity· $200M
Leadership Team
Recent News
MarketScreener
2025-10-27
Company data provided by crunchbase